Research into the pathophysiology of ATP6V0A2 and related conditions is ongoing. Scientists are exploring the molecular mechanisms underlying these disorders and investigating potential therapeutic targets. Advances in gene therapy and precision medicine hold promise for future treatments that could address the root causes of these genetic conditions.
